Ironwood Pharmaceuticals, Inc. logo IRWD - Ironwood Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 11
HOLD 16
SELL 3
STRONG
SELL 0
| PRICE TARGET: $4.80 DETAILS
HIGH: $5.70
LOW: $3.70
MEDIAN: $5.00
CONSENSUS: $4.80
UPSIDE: 22.45%

Profitability Ratios

Ratio Value
GP Margin 100.0%
EBIT Margin 34.7%
EBITDA Margin 35.3%
Operating Margin 40.1%
Pretax Margin 23.6%
Cont. Ops Margin 8.1%
Net Margin 8.1%
Bottom Line Margin 8.1%

Liquidity Ratios

Ratio Value
Current Ratio 1.13
Quick Ratio 1.13
Solvency Ratio 0.039
Cash Ratio 0.89

Valuation Ratios

Ratio Value
Price/Earnings
22.76
Hist. avg: 30.2
Peers avg: 24.3
PEG Ratio 0.01
Forward PEG 0.01
Price/Book -2.09
Price/Sales 1.85
Price/FCF 4.30
Price/Op Cash Flow 4.30

Debt Ratios

Ratio Value
Debt/Assets 1.5062
Debt/Equity -2.2831
Debt/Capital 1.7793
Long-Term Debt/Capital 3.1259
Financial Leverage -1.52

Cash Flow Ratios

Ratio Value
Working Capital Turnover 3.38
Operating Cash Flow Ratio 0.525
Operating Cash Flow/Sales 42.9%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.25
Interest Coverage 3.6267
Short-Term Operating Cash Flow Coverage 0.63
Operating Cash Flow Coverage 0.21
Capital Expenditure Coverage 3736.59
Dividend + Capital Expenditure Coverage 3736.59

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 1.83
EPS 0.148
Debt/Share 3.8871
Cash/Share 1.33
Book Value/Share -1.61
Tangible BV/Share -1.63
Equity/Share -1.61
Operating Cash Flow/Share 0.783
Capital Expenditure/Share 0.000
FCF/Share 0.783

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.343
Earnings Before Tax/EBIT 0.590
Price/Fair Value -2.09
Debt/Market Cap 1.0755
Effective Tax Rate 65.7%
Enterprise Value Multiple 8.88